Clinical Trials Sponsored by DCB Research AG

Total 188 results

DCB Research AG

Not yet recruiting

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes (TIMES)

Diabetes Mellitus, Type 1
Spiden AG
DCB Research AG

Completed

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
Insel Gruppe AG, University Hospital Bern
DCB Research AG

Recruiting

The FibreGum Study - Changing the Course of Obesity in Children (FibreGum)

Adolescent Obesity | Child Obesity | Nutritional and Metabolic Diseases

Switzerland
DCB Research AG
Insel Gruppe AG, University Hospital Bern

Completed

First Clinical Evaluation of a Novel Glucose Non-invasive Sensor Technology in Patients With Type 1 Diabetes (VAARA)

Diabetes Mellitus

Switzerland
University of Bern
DCB Research AG; Insel Gruppe AG, University Hospital Bern

Recruiting

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes (VOCircle)

Diabetes Mellitus

Switzerland
University of Bern
DCB Research AG; Insel Gruppe AG, University Hospital Bern

Recruiting

Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep (Moonwalk)

Hyperglycemia | Hypoglycemia | Diabetes

Switzerland
University of Bern
DCB Research AG; Insel Gruppe AG, University Hospital Bern

Active, not recruiting

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser (VAARABreath)

Glucose Metabolism Disorders | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease

Switzerland
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
MorphoSys AG
ICON Clinical Research

Active, not recruiting

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (B-MIND)

Diffuse Large B-cell Lymphoma

United States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
Clinical Research Consultants, Inc.
Alcon Research; WaveLight AG

Completed

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia

Myopia | Hyperopia

United States
Aposcience AG
FGK Clinical Research GmbH

Completed

A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Diabetic Foot Ulcer (DFU)

Austria, Czechia, Germany, Poland
Immunic AG
FGK Clinical Research GmbH

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)

COVID-19

Bulgaria, Germany
PureIMS B.V.
Cooperative Clinical Drug Research and Development AG (CCDRD AG)

Completed

A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA®

Parkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism

Bulgaria
Medherant Ltd
Cooperative Clinical Drug Research and Development AG (CCDRD AG)

Completed

pK of a Novel 200 mg Ibuprofen Medicated Plaster

Healthy

Bulgaria
Clinical Research Consultants, Inc.
HumanOptics AG

Recruiting

Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

Full Aniridia | Partial Aniridia

United States
Bühlmann Laboratories AG
ICON Clinical Research

Completed

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

Irritable Bowel Syndrome | Inflammatory Bowel Disease

United States
Medherant Ltd
Cooperative Clinical Drug Research and Development AG (CCDRD AG)

Completed

Phase I Study to Assess Irritation, Sensitization and Adhesion of a Novel Ibuprofen 200 mg TEPI Medicated Plaster

Healthy

Bulgaria
Biotronik AG
Medstar Health Research Institute

Unknown

BIOVALVE - I / II Clincial Investigation (BIOVALVE)

Aortic Valve Stenosis | Heart Valve Diseases

Belgium, Germany, Switzerland, Netherlands
UCB BIOSCIENCES, Inc.
Pharmaceutical Research Associates

Completed

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications (VALOR)

Epilepsy

United States, Australia, Belgium, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
IFAG AG
Hiscia Society for Cancer Research; IFAG Basel AG, both Switzerland

Unknown

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Pancreas Cancer

Austria, Germany
UCB Pharma SA
ReSearch Pharmaceutical Services, Inc.

Completed

Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)

Rheumatoid Arthritis

Spain
Sansum Diabetes Research Institute
Roche Pharma AG

Recruiting

Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes (mySugr)

Diabetes Mellitus, Type 2

United States
Spital Davos AG
AO Research Institute Davos

Recruiting

Intraoperativ Testing of Scapholunate Instability in Radius Fracture (ScaLu)

Radius; Dislocation Distal | Scapholunate Dissociation

Switzerland
Polish Lymphoma Research Group
Roche Pharma AG

Terminated

Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse (OPERA-PLRG10)

Mantle Cell Lymphoma

Poland
Pierrel Research Europe GmbH
Roche Pharma AG

Terminated

Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation (CONVINCE)

Allogeneic Stem Cell Transplantation

Austria, Germany, Spain
BioVersys AG
CW-Research and Management GmbH

Recruiting

Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100

Bacterial Infections

Austria
57GGardner
Trialfacts; Philips BioTelemetry Research

Completed

Development of Physical Activity Features for Ear-worn Devices

Hearing Loss | Well Aging

United States
Biotronik AG
CBCC-VIBGYOR Research Pvt. Ltd.

Suspended

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold (BIOSOLVE-India)

Coronary Artery Disease

India
Affectis Pharmaceuticals AG
FGK Clinical Research GmbH

Completed

Cimicoxib for the Treatment of Major Depression (SECIM)

Major Depression

Austria, Czech Republic, Germany
Canadian Immunodeficiency Research Collaborative
Roche Pharma AG

Completed

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Human Immunodeficiency Virus

Canada
Derm Research, PLLC
UCB Pharma

Completed

Management of Pruritus With Xyzal in Atopic Dermatitis

Pruritus | Atopic Dermatitis

United States
IFAG AG
Hiscia Society for Cancer Research; IFAG Basel AG (CRO), both Switzerland

Unknown

Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)

Colorectal Cancer

Austria, Germany
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer (ATREZZO)

Breast Cancer

Spain
The Lymphoma Academic Research Organisation
Roche Pharma AG

Terminated

Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma

France
Cereneo AG
cereneo Institute for Interdsciplinary Research (cefir)

Completed

Survey of Lifelong Food and Nutrition Assistance (LIFANA) in Stroke Patients and Caregivers

Stroke | Diet Modification | Relatives

Switzerland
Medela AG
Joseph M. Still Research Foundation, Inc.

Completed

Evaluating Clinical Acceptance of a NPWT Wound Care System

Diabetic Foot Ulcer | Pressure Ulcer | Pressure Injury

United States
The Lymphoma Academic Research Organisation
Roche Pharma AG

Terminated

Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia (VISMOLY)

Chronic Lymphocytic Leukemia | Primary Central Nervous System Lymphoma | Diffuse Large B-cell Lymphoma | Indolent Non-hodgkin Lymphoma

France
The Lymphoma Academic Research Organisation
Roche Pharma AG

Completed

Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT) (FLIRT)

Follicular Lymphoma

France
Medela AG
Joseph M. Still Research Foundation, Inc.

Completed

A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System

Edema | Surgical Wound | Diabetic Foot Ulcer | Pressure Ulcer | Pressure Injury | Acute Wound | Traumatic Wound | Dehiscence

United States
The Lymphoma Academic Research Organisation
Roche Pharma AG

Recruiting

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

Follicular Lymphoma

France
SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)

Metastatic Breast Cancer

Spain
Mario Negri Institute for Pharmacological Research
MorphoSys AG

Active, not recruiting

MOR202 for Refractory MN (MONET)

Membranous Nephropathy

Italy
Oklahoma Medical Research Foundation
UCB Pharma

Completed

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients (PICS)

Rheumatoid Arthritis

United States
Gastroenterology Research of America
UCB Pharma

Unknown

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

Crohn's Disease

United States
Cancer Research UK
UCB Biopharma SRL

Not yet recruiting

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Uterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Carcinoma, Renal Cell (Clear Cell Only) | Stomach Neoplasms...

United Kingdom
AAADRS Clinical Research Center
UCB Pharma

Completed

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
King's College London
Roche Pharma AG; Medical Research Council

Completed

Study of Rituximab to Treat Chronic Renal Transplant Rejection (RituxiCAN-C4)

Kidney Transplantation | Graft Rejection | Immunosuppression

United Kingdom
LimmaTech Biologics AG
Wellcome Trust; Naval Medical Research Center

Completed

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Shigellosis

United States
Göteborg University
The Swedish Research Council; Roche Pharma AG

Completed

Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 (RibaC)

Hepatitis C

Sweden

Clinical Trials Sponsored by DCB Research AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations